Search published articles


Showing 2 results for Folic Acid

Hr Joshaghani, Aa Shirafcan, Aj Marjani,
Volume 1, Issue 2 (10-2007)
Abstract

Abstract

Introduction:

methionine. Many reports confirm the correlation between hyper

homocysteinemia and cardiovascular disease. This study was aimed

at determining the effect of B12 and folate deficiency on the

homocysteine level after myocardial infarction.

Homocysteine is produced by demethylation of

Materials and methods:

study were patients with myocardial infarction (N = 48) and healthy

patients (N = 48) Eliza method was used to assay Homocysteine and

RIA for folic acid and vitamin B12.

The subjects of This descriptive-analytic

Results:

(30.3 ± 5.3 μm/l) and the control group (11.1 ± 3.1) is significant (p<

0.001). There is no significant difference between Serum B12 in case

(297.1 ± 208.9 pm/l) and control group (261.5 ± 205.3) and it is true

about Serum folic acid of case (3.9 ± 2.9 ng/m) and control group

(4.3 ± 3.5). The homocysteine level of all patients and four of

healthy subjects is higher than normal. The folic acid Level of 11

patients and four healthy subjects is less than normal.

the difference between the homocysteine Level of the case

Conclusion:

of control group and this difference is not related to decrease of B12

Level, Physicians must pay attention to The other risk factors.

since the homocysteine level of patients is there times

Key words:

cobalamine, cardiovascular disease.

Folic acid, Homocysteine, Myocardial Infarction,
Saif Karim, Mahdi Zahedi , Zeinab Mohammadi , Nahid Poursharifi , Mehdi Khorami , Mohsen Tatar ,
Volume 19, Issue 2 (3-2025)
Abstract

Background: Smoking is recognized as a significant risk factor for cardiovascular diseases (CVD), yet its influence on blood levels of homocysteine, folic acid, and vitamin B12 is not well understood. This study aimed to explore how smoking affects these biochemical markers in patients with CVD.
Methods: The study included 88 participants diagnosed with CVD, who were categorized into smokers (n=44) and non-smokers (n=44). Serum concentrations of homocysteine, folic acid, and vitamin B12 were assessed using ELISA. Additionally, blood pressure (both systolic and diastolic) and body mass index (BMI) were recorded.
Results: Smokers showed significantly lower levels of folic acid (22.41 ± 5.95 ng/mL) compared to non-smokers (28.05 ± 4.13 ng/mL, p = 0.000). No significant differences were observed in homocysteine (p = 0.958) or vitamin B12 (p = 0.578) levels between the two groups. A negative correlation was found between folic acid and systolic blood pressure in smokers, while no significant associations were noted among folic acid, vitamin B12, and homocysteine.
Conclusion: In patients with CVD, smoking is linked to significantly lower folic acid levels, which may lead to increased systolic blood pressure. These results underscore the need to monitor folic acid levels in smokers who are at risk for cardiovascular issues.


Page 1 from 1     

© 2007 All Rights Reserved | Medical Laboratory Journal

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.